Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Rating Upgraded by Zacks Research

Reckitt Benckiser Group (OTCMKTS:RBGLY) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.

RBGLY has been the topic of several other reports. Morgan Stanley raised Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a research report on Monday, March 16th. Kepler Capital Markets raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, April 17th. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Reckitt Benckiser Group Stock Up 0.3%

OTCMKTS RBGLY opened at $12.54 on Monday. Reckitt Benckiser Group has a one year low of $12.02 and a one year high of $17.80. The stock has a 50-day moving average of $12.92 and a 200 day moving average of $14.90. The company has a current ratio of 0.85, a quick ratio of 0.63 and a debt-to-equity ratio of 0.98.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.